{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:45:13Z","timestamp":1792601113619,"version":"4.5.0"},"reference-count":38,"publisher":"MyJove Corporation","issue":"209","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/66810","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T20:11:49Z","timestamp":1721419909000},"source":"Crossref","is-referenced-by-count":1,"title":["<em>In Vitro<\/em> Modeling of Fat Deposition in Metabolic Dysfunction-associated Steatotic Liver Disease"],"prefix":"10.3791","author":[{"given":"Qinglan","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tegexibaiyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bateer","family":"Siqin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrgastro.2011.273","type":"journal-article","article-title":"Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach","volume":"9","author":"Alisi","year":"2012","unstructured":"Alisi, A., Feldstein, A. E., Villani, A., Raponi, M. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol. 9 (3), 152-161 (2012).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"19","key":"ref2","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","type":"journal-article","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","unstructured":"Anania, C., Perla, F. M., Olivero, F., Pacifico, L., Chiesa, C. Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol. 24 (19), 2083-2094 (2018).","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","type":"journal-article","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","unstructured":"Bessone, F., Razori, M. V., Roma, M. G. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 76 (1), 99-128 (2019).","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","type":"journal-article","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: An update","volume":"65","author":"Katsiki","year":"2016","unstructured":"Katsiki, N., Mikhailidis, D. P., Mantzoros, C. S. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 65 (8), 1109-1123 (2016).","journal-title":"Metabolism"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","type":"journal-article","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease","volume":"9","year":"2016","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Obes Facts. 9 (2), 65-90 (2016).","journal-title":"Obes Facts"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","type":"journal-article","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 67 (1), 328-357 (2018).","journal-title":"Hepatology"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","type":"journal-article","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","unstructured":"D\u00edaz, L. A., Arab, J. P., Louvet, A., Bataller, R., Arrese, M. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 20 (12), 764-783 (2023).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","type":"journal-article","article-title":"Nonalcoholic fatty liver disease 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","unstructured":"Cotter, T. G., Rinella, M. Nonalcoholic fatty liver disease 2020: The state of the disease. Gastroenterology. 158 (7), 1851-1864 (2020).","journal-title":"Gastroenterology"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","type":"journal-article","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","unstructured":"Lonardo, A. et al. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation. Nat Rev Endocrinol. 18 (10), 638-650 (2022).","journal-title":"Nat Rev Endocrinol"},{"issue":"38","key":"ref10","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","type":"journal-article","article-title":"Diagnosis of non-alcoholic fatty liver disease (NAFLD): Current concepts","volume":"24","author":"Papatheodoridi","year":"2018","unstructured":"Papatheodoridi, M., Cholongitas, E. Diagnosis of non-alcoholic fatty liver disease (NAFLD): Current concepts. Curr Pharm Des. 24 (38), 4574-4586 (2018).","journal-title":"Curr Pharm Des"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/nu9101072","type":"journal-article","article-title":"Animal models of nonalcoholic fatty liver disease-a starter's guide","volume":"9","author":"Van Herck","year":"2017","unstructured":"Van Herck, M. A., Vonghia, L., Francque, S. M. Animal models of nonalcoholic fatty liver disease-a starter's guide. Nutrients. 9 (10), 1072 (2017).","journal-title":"Nutrients"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","type":"journal-article","article-title":"Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive","volume":"28","author":"Wieckowska","year":"2008","unstructured":"Wieckowska, A., Feldstein, A. E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 28 (4), 386-395 (2008).","journal-title":"Semin Liver Dis"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12325-009-0072-z","type":"journal-article","article-title":"Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status","volume":"26","author":"Stein","year":"2009","unstructured":"Stein, L. L., Dong, M. H., Loomba, R. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. Adv Ther. 26 (10), 893-907 (2009).","journal-title":"Adv Ther"},{"issue":"28","key":"ref14","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","type":"journal-article","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","unstructured":"Mili\u0107, S., Luli\u0107, D., \u0160timac, D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 20 (28), 9330-9337 (2014).","journal-title":"World J Gastroenterol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","type":"journal-article","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri, B. A., Caldwell, S. H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 37 (5), 1202-1219 (2003).","journal-title":"Hepatology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"2179334","DOI":"10.1080\/21623945.2023.2179334","type":"journal-article","article-title":"An optimized method for Oil Red O staining with the salicylic acid ethanol solution","volume":"12","author":"Du","year":"2023","unstructured":"Du, J., Zhao, L., Kang, Q., He, Y., Bi, Y. An optimized method for Oil Red O staining with the salicylic acid ethanol solution. Adipocyte. 12 (1), 2179334 (2023).","journal-title":"Adipocyte"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","type":"journal-article","article-title":"Imaging of neutral lipids by Oil Red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","unstructured":"Mehlem, A., Hagberg, C. E., Muhl, L., Eriksson, U., Falkevall, A. Imaging of neutral lipids by Oil Red O for analyzing the metabolic status in health and disease. Nat Protoc. 8 (6), 1149-1154 (2013).","journal-title":"Nat Protoc"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","type":"journal-article","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z., Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 67 (1), 123-133 (2018).","journal-title":"Hepatology"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.bbadis.2012.02.010","type":"journal-article","article-title":"Peroxisomal acyl-CoA synthetases","volume":"1822","author":"Watkins","year":"2012","unstructured":"Watkins, P. A., Ellis, J. M. Peroxisomal acyl-CoA synthetases. Biochim Biophys Acta. 1822 (9), 1411-1420 (2012).","journal-title":"Biochim Biophys Acta"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","type":"journal-article","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","unstructured":"Heeren, J., Scheja, L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 50, 101238, (2021).","journal-title":"Mol Metab"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/molecules28031476","type":"journal-article","article-title":"Effect of isoquercitrin on free fatty acid-induced lipid accumulation in HepG2 cells","volume":"28","author":"Kim","year":"2023","unstructured":"Kim, S. H. et al. Effect of isoquercitrin on free fatty acid-induced lipid accumulation in HepG2 cells. Molecules. 28 (3), 1476 (2023).","journal-title":"Molecules"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phymed.2018.07.008","type":"journal-article","article-title":"Lycopus lucidus Turcz. ex Benth. attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice","volume":"55","author":"Lee","year":"2019","unstructured":"Lee, M. R., Yang, H. J., Park, K. I., Ma, J. Y. Lycopus lucidus Turcz. ex Benth. attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Phytomedicine. 55, 14-22, (2019).","journal-title":"Phytomedicine"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","type":"journal-article","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","unstructured":"Li, J. et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 12 (9), 3898-3918 (2021).","journal-title":"Food Funct"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"114319","DOI":"10.1016\/j.biopha.2023.114319","type":"journal-article","article-title":"Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway","volume":"160","author":"Li","year":"2023","unstructured":"Li, Y. et al. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway. Biomed Pharmacother. 160, 114319, (2023).","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"159287","DOI":"10.1016\/j.bbalip.2023.159287","type":"journal-article","article-title":"Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells","volume":"1868","author":"Liu","year":"2023","unstructured":"Liu, H. et al. Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells. Biochim Biophys Acta Mol Cell Biol Lipids. 1868 (4), 159287 (2023).","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/nu11102536","type":"journal-article","article-title":"Water extract of Curcuma longa L. ameliorates non-alcoholic fatty liver disease","volume":"11","author":"Mun","year":"2019","unstructured":"Mun, J. et al. Water extract of Curcuma longa L. ameliorates non-alcoholic fatty liver disease. Nutrients. 11 (10), 2536 (2019).","journal-title":"Nutrients"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/nu11030494","type":"journal-article","article-title":"Lonicera caerulea extract attenuates non-alcoholic fatty liver disease in free fatty acid-induced HepG2 hepatocytes and in high fat diet-fed mice","volume":"11","author":"Park","year":"2019","unstructured":"Park, M., Yoo, J. H., Lee, Y. S., Lee, H. J. Lonicera caerulea extract attenuates non-alcoholic fatty liver disease in free fatty acid-induced HepG2 hepatocytes and in high fat diet-fed mice. Nutrients. 11 (3), 494 (2019).","journal-title":"Nutrients"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"109287","DOI":"10.1016\/j.biopha.2019.109287","type":"journal-article","article-title":"Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice","volume":"118","author":"Xia","year":"2019","unstructured":"Xia, H. et al. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. Biomed Pharmacother. 118, 109287 (2019).","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3892\/etm.2016.3069","type":"journal-article","article-title":"Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG(2) cells: An in vitro model of non-alcoholic fatty liver disease","volume":"11","author":"Alkhatatbeh","year":"2016","unstructured":"Alkhatatbeh, M. J., Lincz, L. F., Thorne, R. F. Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG(2) cells: An in vitro model of non-alcoholic fatty liver disease. Exp Ther Med. 11 (4), 1487-1492 (2016).","journal-title":"Exp Ther Med"},{"issue":"1","key":"ref30","first-page":"95","type":"journal-article","article-title":"Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells","volume":"2","author":"Cui","year":"2010","unstructured":"Cui, W., Chen, S. L., Hu, K. Q. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res. 2 (1), 95-104 (2010).","journal-title":"Am J Transl Res"},{"issue":"24","key":"ref31","doi-asserted-by":"crossref","first-page":"15489","DOI":"10.3390\/ijms232415489","type":"journal-article","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","unstructured":"Guo, X., Yin, X., Liu, Z., Wang, J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 23 (24), 15489 (2022).","journal-title":"Int J Mol Sci"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/nu11030541","type":"journal-article","article-title":"Dietary polyphenols protect against oleic acid-induced steatosis in an in vitro model of NAFLD by modulating lipid metabolism and improving mitochondrial function","volume":"11","author":"Rafiei","year":"2019","unstructured":"Rafiei, H., Omidian, K., Bandy, B. Dietary polyphenols protect against oleic acid-induced steatosis in an in vitro model of NAFLD by modulating lipid metabolism and improving mitochondrial function. Nutrients. 11 (3), 541 (2019).","journal-title":"Nutrients"},{"issue":"16","key":"ref33","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.3390\/ijms22168847","type":"journal-article","article-title":"Kaempferol and kaempferide attenuate oleic acid-Induced lipid accumulation and oxidative stress in HepG2 cells","volume":"22","author":"Tie","year":"2021","unstructured":"Tie, F. et al. Kaempferol and kaempferide attenuate oleic acid-Induced lipid accumulation and oxidative stress in HepG2 cells. Int J Mol Sci. 22 (16), 8847 (2021).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12906-019-2671-9","type":"journal-article","article-title":"Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK\/ACC\/CPT-1A and SREBP-1c\/FAS signaling pathways in LO2 cells","volume":"19","author":"Fang","year":"2019","unstructured":"Fang, K. et al. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK\/ACC\/CPT-1A and SREBP-1c\/FAS signaling pathways in LO2 cells. BMC Complement Altern Med. 19 (1), 255 (2019).","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","type":"journal-article","article-title":"MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis","volume":"73","author":"Wu","year":"2020","unstructured":"Wu, X. et al. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J Hepatol. 73 (3), 616-627 (2020).","journal-title":"J Hepatol"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41419-023-06161-9","type":"journal-article","article-title":"The oleic\/palmitic acid imbalance in exosomes isolated from NAFLD patients induces necroptosis of liver cells via the elongase-6\/RIP-1 pathway","volume":"14","author":"Scavo","year":"2023","unstructured":"Scavo, M. P. et al. The oleic\/palmitic acid imbalance in exosomes isolated from NAFLD patients induces necroptosis of liver cells via the elongase-6\/RIP-1 pathway. Cell Death Dis. 14 (9), 635 (2023).","journal-title":"Cell Death Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-12-20","type":"journal-article","article-title":"Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease","volume":"12","author":"Chavez-Tapia","year":"2012","unstructured":"Chavez-Tapia, N. C., Rosso, N., Tiribelli, C. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol. 12, 20 (2012).","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","type":"journal-article","article-title":"Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes","volume":"24","author":"Ricchi","year":"2009","unstructured":"Ricchi, M. et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol. 24 (5), 830-840 (2009).","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/66810\/in-vitro-modeling-fat-deposition-metabolic-dysfunction-associated","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:15:34Z","timestamp":1792599334000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/66810\/in-vitro-modeling-fat-deposition-metabolic-dysfunction-associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":38,"journal-issue":{"issue":"209","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3791\/66810","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}